SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-057341
Filing Date
2015-08-07
Accepted
2015-08-06 20:43:31
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-11925_310q.htm 10-Q 1050164
2 EX-31.1 a15-11925_3ex31d1.htm EX-31.1 10376
3 EX-31.2 a15-11925_3ex31d2.htm EX-31.2 10423
4 EX-32.1 a15-11925_3ex32d1.htm EX-32.1 6825
5 EX-32.2 a15-11925_3ex32d2.htm EX-32.2 6844
  Complete submission text file 0001104659-15-057341.txt   5357095

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT supn-20150630.xml EX-101.INS 1220886
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20150630.xsd EX-101.SCH 39046
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT supn-20150630_cal.xml EX-101.CAL 62452
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT supn-20150630_def.xml EX-101.DEF 122404
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT supn-20150630_lab.xml EX-101.LAB 405613
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20150630_pre.xml EX-101.PRE 274908
Mailing Address 1550 E GUDE DR ROCKVILLE MD 20850
Business Address 1550 E GUDE DR ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS INC (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-35518 | Film No.: 151034740
SIC: 2834 Pharmaceutical Preparations